dynavax
Hep-B vaccine four-year battle for FDA approval is finally won
November 10, 2017Medical Communications, Sales and Marketing biotech, drugs, dynavax, hepatitis B, pharma, pharmaceutical
Dynavax had said it was the last throw of the dice for its hepatitis B vaccine, Hepislav-B – the data …
FDA to review investigational hepatitis B vaccine
April 1, 2016Medical Communications, Research and Development dynavax, hepatitis B, vaccines
Dynavax Technologies (NASDAQ: DVAX) says the FDA has accepted for review the company’s investigational adult hepatitis B vaccine, HEPLISAV-B. The FDA has set …
Merck tests new Keytruda combination
June 3, 2015Research and Development, Sales and Marketing Merck, dynavax, keytruda
Merck is continuing to investigate Keytruda combinations as it signs a deal to test the drug with an immunotherapy from …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
